Terpenoid ID | TKC011921 | |
Chirality | TKC104764 | |
Cell line | 0 | |
Protein target | 14 | |
DiseaseNCIT | 0 | |
ORDO | 0 | |
ICD | 19 |
ID | Cell Line | Synonyms | Value | Unit | Type | NCIt | ORDO |
---|---|---|---|---|---|---|---|
TKC011921 | H4 | H-4 | 73.0 | % | Activity | C60781 | Orphanet_94 |
TKC011921 | Vero | VERO; VeroCCL81; Vero 81; Vero-81; Verda reno | 580.0 | nM | IC50 | ||
TKC011921 | HEK293 | 731.0 | nM | Potency | |||
TKC011921 | HCT-116 | HCT-116; HCT.116; HCT_116; HCT116; HCT116wt; CoCL2 | 9000.0 | nM | IC50 | C4910 | |
TKC011921 | HL | Human Lung | 92.0 | % | Activity | ||
TKC011921 | HL-60 | HL 60; HL.60 HL60; Human Leukemia-60 | 24400.0 | nM | IC50 | C9154 | Orphanet_519 |
ID | Uniport | Pref_name | Gene name | value | unit | type |
---|---|---|---|---|---|---|
TKC011921 | Q16637 | Survival motor neuron protein | SMN1,SMN2 | 794 | nM | Potency |
TKC011921 | Q16637 | Survival motor neuron protein | SMN1,SMN2 | 794 | nM | Potency |
TKC011921 | Q9NUW8 | Tyrosyl-DNA phosphodiesterase 1 | TDP1 | 104 | nM | Potency |
TKC011921 | P27695 | DNA-(apurinic or apyrimidinic site) endonuclease | APEX1 | 39811 | nM | Potency |
TKC011921 | O42275 | Acetylcholinesterase | ache | 8 | % | Inhibition |
TKC011921 | P0DTD1 | Replicase polyprotein 1ab | rep | 11 | % | Inhibition |
TKC011921 | P81908 | Cholinesterase | BCHE | 13 | % | Inhibition |
TKC011921 | Q96KQ7 | Histone-lysine N-methyltransferase EHMT2 | EHMT2 | 6310 | nM | Potency |
TKC011921 | P46063 | ATP-dependent DNA helicase Q1 | RECQL | 5623 | nM | Potency |
TKC011921 | P06746 | DNA polymerase beta | POLB | >100000 | nM | IC50 |
TKC011921 | Q16665 | Hypoxia-inducible factor 1-alpha | HIF1A | 1995 | nM | Potency |
TKC011921 | P02545 | Prelamin-A/C | LMNA | 794 | nM | Potency |
TKC011921 | P04292 | DNA polymerase catalytic subunit | UL30 | 438 | nM | IC50 |
TKC011921 | P04292 | DNA polymerase catalytic subunit | UL30 | 500 | nM | IC50 |
TKC011921 | P06766 | DNA polymerase beta | Polb | >100000 | nM | IC50 |
TKC011921 | P08546 | DNA polymerase catalytic subunit | UL54 | 400 | nM | IC50 |
TKC011921 | P08546 | DNA polymerase catalytic subunit | UL54 | 487 | nM | IC50 |
TKC011921 | P09252 | DNA polymerase catalytic subunit | ORF28 | 600 | nM | IC50 |
TKC011921 | P09884 | DNA polymerase alpha catalytic subunit | POLA1 | 2000 | nM | EC50 |
TKC011921 | P09884 | DNA polymerase alpha catalytic subunit | POLA1 | 3000 | nM | IC50 |
TKC011921 | P09884 | DNA polymerase alpha catalytic subunit | POLA1 | 2600 | nM | IC50 |
TKC011921 | P09884 | DNA polymerase alpha catalytic subunit | POLA1 | 2600 | nM | IC50 |
TKC011921 | P09884 | DNA polymerase alpha catalytic subunit | POLA1 | 16000 | nM | IC50 |
TKC011921 | P09884 | DNA polymerase alpha catalytic subunit | POLA1 | 2400 | nM | IC50 |
TKC011921 | P28340 | DNA polymerase delta catalytic subunit | POLD1 | >40000 | nM | IC50 |
TKC011921 | P28857 | DNA polymerase catalytic subunit | U38 | 400 | nM | IC50 |
TKC011921 | P42858 | Huntingtin | HTT | 631 | nM | Potency |
TKC011921 | P54098 | DNA polymerase subunit gamma-1 | POLG | >100000 | nM | IC50 |
TKC011921 | Q9UGP5 | DNA polymerase lambda | POLL | >200000 | nM | IC50 |
TKC011921 | Q13285 | Steroidogenic factor 1 | NR5A1 | 550 | nM | IC50 |
TKC011921 | Q13285 | Steroidogenic factor 1 | NR5A1 | 519 | nM | IC50 |
Uniport ID | Uniport Name | ICD-11 |
---|---|---|
Q16637 | SMN_HUMAN | Muscular atrophy [ICD-11: 8B61] |
Q16637 | SMN_HUMAN | Muscular atrophy [ICD-11: 8B61] |
Q16637 | SMN_HUMAN | Muscular atrophy [ICD-11: 8B61] |
Q16637 | SMN_HUMAN | Muscular atrophy [ICD-11: 8B61] |
P27695 | APEX1_HUMAN | Retinopathy [ICD-11: 9B71] |
P27695 | APEX1_HUMAN | Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P27695 | APEX1_HUMAN | Ocular cancer [ICD-11: 2D00-2D07] |
P27695 | APEX1_HUMAN | Brain cancer [ICD-11: 2A00] |
P27695 | APEX1_HUMAN | Melanoma [ICD-11: 2C30] |
Q96KQ7 | EHMT2_HUMAN | Breast cancer [ICD-11: 2C60-2C6Y] |
Q96KQ7 | EHMT2_HUMAN | Postoperative inflammation [ICD-11: 1A00-CA43] |
Q96KQ7 | EHMT2_HUMAN | Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P06746 | DPOLB_HUMAN | Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
Q16665 | HIF1A_HUMAN | Adrenomedullary hyperfunction [ICD-11: 5A75] |
Q16665 | HIF1A_HUMAN | Brain cancer [ICD-11: 2A00] |
Q16665 | HIF1A_HUMAN | Lymphoma [ICD-11: 2A80-2A86] |
Q16665 | HIF1A_HUMAN | Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
Q16665 | HIF1A_HUMAN | Pulmonary hypertension [ICD-11: BB01] |
P08546 | DPOL_HCMVA | Cytomegaloviral disease [ICD-11: 1D82] |
P08546 | DPOL_HCMVA | Cytomegaloviral disease [ICD-11: 1D82] |
P09252 | DPOL_VZVD | Herpes simplex infection [ICD-11: 1F00] |
P09252 | DPOL_VZVD | Virus infection [ICD-11: 1A24-1D9Z] |
P09884 | DPOLA_HUMAN | Virus infection [ICD-11: 1A24-1D9Z] |
P09884 | DPOLA_HUMAN | Virus infection [ICD-11: 1A24-1D9Z] |
P09884 | DPOLA_HUMAN | Virus infection [ICD-11: 1A24-1D9Z] |
P09884 | DPOLA_HUMAN | Virus infection [ICD-11: 1A24-1D9Z] |
P09884 | DPOLA_HUMAN | Virus infection [ICD-11: 1A24-1D9Z] |
P09884 | DPOLA_HUMAN | Virus infection [ICD-11: 1A24-1D9Z] |
P42858 | HD_HUMAN | Choreiform disorder [ICD-11: 8A01] |